Mereo BioPharma (MREO) Times Interest Earned (2023 - 2026)
Mereo BioPharma (MREO) reported Times Interest Earned of -$438.3 for Q1 2026, down 604.28% year-over-year from $86.92 in Q1 2025, and down 20.15% quarter-over-quarter from -$364.78 in Q4 2025.
Mereo BioPharma (MREO) Times Interest Earned (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Times Interest Earned data on file, last reported at -$438.3 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$438.3, down 604.28% year-over-year; the trailing twelve-month figure through Mar 2026 was -$396.53 (down 5237.47% YoY), and the FY2025 annual result was -$157.28, down 2083.58% from the prior year.
- Times Interest Earned slipped to -$438.3 in Q1 2026 per MREO's latest filing, from -$364.78 in the prior quarter.
- Over five years, Times Interest Earned peaked at $114.54 in Q4 2024 and troughed at -$438.3 in Q1 2026.
- A 4-year average of -$130.1 and a median of -$31.94 in 2024 frame the typical range for Times Interest Earned.
- On a YoY basis, Times Interest Earned climbed as much as 667.23% in 2024 and fell as far as 4811.92% in 2024.
- A 4-year view of Times Interest Earned shows it stood at -$20.19 in 2023, then soared by 667.23% to $114.54 in 2024, then tumbled by 418.48% to -$364.78 in 2025, then declined by 20.15% to -$438.3 in 2026.
- Business Quant data shows MREO's Times Interest Earned at -$438.3 in Q1 2026, -$364.78 in Q4 2025, and -$357.68 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -438.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -438.30 |
| Dec 31, 2025 | -364.78 |
| Sep 30, 2025 | -357.68 |
| Jun 30, 2025 | -437.46 |
| Mar 31, 2025 | -62.23 |
| Dec 31, 2024 | 114.54 |
| Sep 30, 2024 | -26.55 |
| Jun 30, 2024 | -38.71 |
| Mar 31, 2024 | -31.94 |
| Dec 31, 2023 | -20.19 |
| Sep 30, 2023 | -12.95 |
| Jun 30, 2023 | -0.79 |
| Mar 31, 2023 | -14.26 |